Global Drug Repurposing Market Growth (Status and Outlook) 2022-2028
- LP 4860973
- 86 Pages
- February 2022
- Medical Devices
The United States Drug Repurposing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug Repurposing market, reaching US$ million by the year 2028. As for the Europe Drug Repurposing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drug Repurposing players cover Pfizer, Roche, Novartis AG, and Abbott Healthcare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Repurposing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Intravenous
Oral
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cardiovascular Disorders
Central Nervous Disorders
Oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Roche
Novartis AG
Abbott Healthcare
Johnson & Johnson
Sandoz
Mylan Inc.
Teva Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Repurposing Market Size 2017-2028
2.1.2 Drug Repurposing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug Repurposing Segment by Type
2.2.1 Intravenous
2.2.2 Oral
2.3 Drug Repurposing Market Size by Type
2.3.1 Drug Repurposing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug Repurposing Market Size Market Share by Type (2017-2022)
2.4 Drug Repurposing Segment by Application
2.4.1 Cardiovascular Disorders
2.4.2 Central Nervous Disorders
2.4.3 Oncology
2.4.4 Others
2.5 Drug Repurposing Market Size by Application
2.5.1 Drug Repurposing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug Repurposing Market Size Market Share by Application (2017-2022)
3 Drug Repurposing Market Size by Player
3.1 Drug Repurposing Market Size Market Share by Players
3.1.1 Global Drug Repurposing Revenue by Players (2020-2022)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2020-2022)
3.2 Global Drug Repurposing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Repurposing by Regions
4.1 Drug Repurposing Market Size by Regions (2017-2022)
4.2 Americas Drug Repurposing Market Size Growth (2017-2022)
4.3 APAC Drug Repurposing Market Size Growth (2017-2022)
4.4 Europe Drug Repurposing Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug Repurposing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drug Repurposing Market Size by Country (2017-2022)
5.2 Americas Drug Repurposing Market Size by Type (2017-2022)
5.3 Americas Drug Repurposing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Repurposing Market Size by Region (2017-2022)
6.2 APAC Drug Repurposing Market Size by Type (2017-2022)
6.3 APAC Drug Repurposing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Repurposing by Country (2017-2022)
7.2 Europe Drug Repurposing Market Size by Type (2017-2022)
7.3 Europe Drug Repurposing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Repurposing by Region (2017-2022)
8.2 Middle East & Africa Drug Repurposing Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug Repurposing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Repurposing Market Forecast
10.1 Global Drug Repurposing Forecast by Regions (2023-2028)
10.1.1 Global Drug Repurposing Forecast by Regions (2023-2028)
10.1.2 Americas Drug Repurposing Forecast
10.1.3 APAC Drug Repurposing Forecast
10.1.4 Europe Drug Repurposing Forecast
10.1.5 Middle East & Africa Drug Repurposing Forecast
10.2 Americas Drug Repurposing Forecast by Country (2023-2028)
10.2.1 United States Drug Repurposing Market Forecast
10.2.2 Canada Drug Repurposing Market Forecast
10.2.3 Mexico Drug Repurposing Market Forecast
10.2.4 Brazil Drug Repurposing Market Forecast
10.3 APAC Drug Repurposing Forecast by Region (2023-2028)
10.3.1 China Drug Repurposing Market Forecast
10.3.2 Japan Drug Repurposing Market Forecast
10.3.3 Korea Drug Repurposing Market Forecast
10.3.4 Southeast Asia Drug Repurposing Market Forecast
10.3.5 India Drug Repurposing Market Forecast
10.3.6 Australia Drug Repurposing Market Forecast
10.4 Europe Drug Repurposing Forecast by Country (2023-2028)
10.4.1 Germany Drug Repurposing Market Forecast
10.4.2 France Drug Repurposing Market Forecast
10.4.3 UK Drug Repurposing Market Forecast
10.4.4 Italy Drug Repurposing Market Forecast
10.4.5 Russia Drug Repurposing Market Forecast
10.5 Middle East & Africa Drug Repurposing Forecast by Region (2023-2028)
10.5.1 Egypt Drug Repurposing Market Forecast
10.5.2 South Africa Drug Repurposing Market Forecast
10.5.3 Israel Drug Repurposing Market Forecast
10.5.4 Turkey Drug Repurposing Market Forecast
10.5.5 GCC Countries Drug Repurposing Market Forecast
10.6 Global Drug Repurposing Forecast by Type (2023-2028)
10.7 Global Drug Repurposing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Drug Repurposing Product Offered
11.1.3 Pfizer Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Drug Repurposing Product Offered
11.2.3 Roche Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Drug Repurposing Product Offered
11.3.3 Novartis AG Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Abbott Healthcare
11.4.1 Abbott Healthcare Company Information
11.4.2 Abbott Healthcare Drug Repurposing Product Offered
11.4.3 Abbott Healthcare Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abbott Healthcare Main Business Overview
11.4.5 Abbott Healthcare Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Drug Repurposing Product Offered
11.5.3 Johnson & Johnson Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Drug Repurposing Product Offered
11.6.3 Sandoz Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Sandoz Main Business Overview
11.6.5 Sandoz Latest Developments
11.7 Mylan Inc.
11.7.1 Mylan Inc. Company Information
11.7.2 Mylan Inc. Drug Repurposing Product Offered
11.7.3 Mylan Inc. Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Mylan Inc. Main Business Overview
11.7.5 Mylan Inc. Latest Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Information
11.8.2 Teva Pharmaceuticals Drug Repurposing Product Offered
11.8.3 Teva Pharmaceuticals Drug Repurposing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Teva Pharmaceuticals Main Business Overview
11.8.5 Teva Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Drug Repurposing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Intravenous
Table 3. Major Players of Oral
Table 4. Drug Repurposing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 7. Drug Repurposing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 10. Global Drug Repurposing Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Drug Repurposing Revenue Market Share by Player (2020-2022)
Table 12. Drug Repurposing Key Players Head office and Products Offered
Table 13. Drug Repurposing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Repurposing Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Drug Repurposing Market Size Market Share by Regions (2017-2022)
Table 18. Americas Drug Repurposing Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Drug Repurposing Market Size Market Share by Country (2017-2022)
Table 20. Americas Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 22. Americas Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 24. APAC Drug Repurposing Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Drug Repurposing Market Size Market Share by Region (2017-2022)
Table 26. APAC Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 28. APAC Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 30. Europe Drug Repurposing Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Drug Repurposing Market Size Market Share by Country (2017-2022)
Table 32. Europe Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 34. Europe Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Drug Repurposing Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Drug Repurposing Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Drug Repurposing Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drug Repurposing Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Drug Repurposing Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drug Repurposing Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Drug Repurposing
Table 43. Key Market Challenges & Risks of Drug Repurposing
Table 44. Key Industry Trends of Drug Repurposing
Table 45. Global Drug Repurposing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Drug Repurposing Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Drug Repurposing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Drug Repurposing Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Drug Repurposing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Drug Repurposing Market Size Market Share Forecast by Application (2023-2028)
Table 51. Pfizer Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 52. Pfizer Drug Repurposing Product Offered
Table 53. Pfizer Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Roche Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 57. Roche Drug Repurposing Product Offered
Table 58. Roche Main Business
Table 59. Roche Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Roche Latest Developments
Table 61. Novartis AG Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 62. Novartis AG Drug Repurposing Product Offered
Table 63. Novartis AG Main Business
Table 64. Novartis AG Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Novartis AG Latest Developments
Table 66. Abbott Healthcare Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 67. Abbott Healthcare Drug Repurposing Product Offered
Table 68. Abbott Healthcare Main Business
Table 69. Abbott Healthcare Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Abbott Healthcare Latest Developments
Table 71. Johnson & Johnson Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 72. Johnson & Johnson Drug Repurposing Product Offered
Table 73. Johnson & Johnson Main Business
Table 74. Johnson & Johnson Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Johnson & Johnson Latest Developments
Table 76. Sandoz Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 77. Sandoz Drug Repurposing Product Offered
Table 78. Sandoz Main Business
Table 79. Sandoz Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Sandoz Latest Developments
Table 81. Mylan Inc. Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 82. Mylan Inc. Drug Repurposing Product Offered
Table 83. Mylan Inc. Main Business
Table 84. Mylan Inc. Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Mylan Inc. Latest Developments
Table 86. Teva Pharmaceuticals Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 87. Teva Pharmaceuticals Drug Repurposing Product Offered
Table 88. Teva Pharmaceuticals Main Business
Table 89. Teva Pharmaceuticals Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Teva Pharmaceuticals Latest Developments
List of Figures
Figure 1. Drug Repurposing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Repurposing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug Repurposing Market Size Market Share by Type in 2021
Figure 7. Drug Repurposing in Cardiovascular Disorders
Figure 8. Global Drug Repurposing Market: Cardiovascular Disorders (2017-2022) & ($ Millions)
Figure 9. Drug Repurposing in Central Nervous Disorders
Figure 10. Global Drug Repurposing Market: Central Nervous Disorders (2017-2022) & ($ Millions)
Figure 11. Drug Repurposing in Oncology
Figure 12. Global Drug Repurposing Market: Oncology (2017-2022) & ($ Millions)
Figure 13. Drug Repurposing in Others
Figure 14. Global Drug Repurposing Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Drug Repurposing Market Size Market Share by Application in 2021
Figure 16. Global Drug Repurposing Revenue Market Share by Player in 2021
Figure 17. Global Drug Repurposing Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Drug Repurposing Market Size 2017-2022 ($ Millions)
Figure 19. APAC Drug Repurposing Market Size 2017-2022 ($ Millions)
Figure 20. Europe Drug Repurposing Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Drug Repurposing Market Size 2017-2022 ($ Millions)
Figure 22. Americas Drug Repurposing Value Market Share by Country in 2021
Figure 23. Americas Drug Repurposing Consumption Market Share by Type in 2021
Figure 24. Americas Drug Repurposing Market Size Market Share by Application in 2021
Figure 25. United States Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Drug Repurposing Market Size Market Share by Region in 2021
Figure 30. APAC Drug Repurposing Market Size Market Share by Application in 2021
Figure 31. China Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Drug Repurposing Market Size Market Share by Country in 2021
Figure 38. Europe Drug Repurposing Market Size Market Share by Type in 2021
Figure 39. Europe Drug Repurposing Market Size Market Share by Application in 2021
Figure 40. Germany Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Drug Repurposing Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Drug Repurposing Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Drug Repurposing Market Size Market Share by Application in 2021
Figure 48. Egypt Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Drug Repurposing Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 54. APAC Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 55. Europe Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 57. United States Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 58. Canada Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 61. China Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 62. Japan Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 63. Korea Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 65. India Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 66. Australia Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 67. Germany Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 68. France Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 69. UK Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 70. Italy Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 71. Russia Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 72. Spain Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 75. Israel Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Drug Repurposing Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Drug Repurposing Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
